Point72 Asset Management
ROIV icon

Point72 Asset Management’s Roivant Sciences ROIV Stock Holding History

Point72 Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.7M Buy
+890,900
New +$22.9M 0.03% 699
2025
Q4 		– Sell
-2,608,294
Closed -$51.5M – 4128
2025
Q3 		$39.5M Sell
2,608,294
-342,838
-12% -$4.24M 0.07% 316
2025
Q2 		$33.3M Buy
2,951,132
+2,336,817
+380% +$25.3M 0.07% 339
2025
Q1 		$6.2M Buy
+614,315
New +$6.64M 0.01% 848
2024
Q3 		– Sell
-647,126
Closed -$6.84M – 2290
2024
Q2 		$6.84M Buy
647,126
+185,226
+40% +$2.03M 0.02% 752
2024
Q1 		$4.87M Buy
461,900
+28,200
+7% +$304K 0.01% 972
2023
Q4 		$4.87M Sell
433,700
-2,272,700
-84% -$22.1M 0.01% 933
2023
Q3 		$31.6M Buy
+2,706,400
New +$30.6M 0.09% 283
2023
Q1 		– Sell
-576,800
Closed -$4.61M – 2507
2022
Q4 		$4.61M Buy
+576,800
New +$3.21M 0.02% 776
2022
Q3 		– Sell
-876,996
Closed -$3.57M – 1686
2022
Q2 		$3.57M Buy
+876,996
New +$3.48M 0.02% 793

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Point72 Asset Management's ROIV Position: Q1 2026 in Review

Point72 Asset Management opened a new position in Roivant Sciences (ROIV) in Q1 2026: 890,900 shares worth $24.7M. The stake represents 0.03% of the portfolio and ranks #699 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in ROIV as recently as Q3 2025.

Point72 Asset Management first reported a position in ROIV in Q2 2022 and has held it in 10 quarters since. The position peaked at $39.5M in Q3 2025. 440 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Point72 Asset Management held 890,900 shares of Roivant Sciences worth $24.7M as of Q1 2026.
  • Roivant Sciences was a new Point72 Asset Management position in Q1 2026.
  • Roivant Sciences made up 0.03% of Point72 Asset Management's portfolio in Q1 2026, its #699 holding.
  • Point72 Asset Management first reported a position in Roivant Sciences in Q2 2022 and has held it in 10 quarters since.
  • Point72 Asset Management's Roivant Sciences position peaked at $39.5M in Q3 2025.
  • 440 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.